About Us

Company Leaders

The SOLIUS team is comprised of seasoned technology and healthcare executives with a passion for social entrepreneurship and for developing products, services and companies that have a positive impact on the health of humanity. This leadership team has decades of experience building successful, innovative, entrepreneurial companies, including ones focused on medical device products and the healthcare marketplace. We have also gathered scientific and medical advisors that have made light science, biomimicry, vitamin D research, and global health their life-long endeavor. Our leaders joined SOLIUS because we plan to change the world by improving the lives of hundreds of millions of people.

Rick Hennessey, Chief Executive Officer

Rick HennesseyRick has been successfully building early stage businesses in high growth markets for over 20 years and is an accomplished entrepreneur, angel investor, and a business advisor. He has built and successfully sold his last five businesses.  All his companies have become profitable.  His last firm raised $8 million dollars and sold for over $100 million in four years.  He is well respected in the business and service community and speaks globally at technology conferences.  Rick has sat on boards, advisory committees and has been President and CEO of two publicly traded companies. In each of the markets Rick has tackled, he has embraced the industry’s community by being involved in industry committees, political initiatives, standards boards, and by speaking at conferences.

Bob Wise, Chief Financial Officer

Bob WiseBob is an experienced operations and financial executive who has helped guide many companies through periods exponential growth.  As President of the Healthcare at Nuance Communications Bob built a team of 3000 medical professionals who were the market leader in voice recognition transcription for electronic medical records providers and clinical information systems.  Bob’s team acquired twenty companies and increased revenue to $375 million per year with operations in 11 countries.  Prior the joining Nuance Bob was the EVP of Corporate Development for MarchFIRST a 9000 person global internet development firm where he participated in taking the company public and developed relationships that resulted in strategic investments of hundreds of millions of dollars from leading companies including IBM, Microsoft and many others.  Prior to March FIRST Bob was the VP of Global Professional Services for Novell and CEO of USConnect.  Bob holds a BS degree in Computer Information Systems from the University of Puget Sound.

Kyle Diercks, Chief Revenue Officer

Kyle DiercksKyle has more than twenty years of senior level business experience with an emphasis in the healthcare and wellness communities and consulting in support of better patient experience. Kyle is an accomplished entrepreneur and speaker on global health and wellness, business development, international relations, leadership, marketing and branding.  Kyle built one of the first sports management agencies in Asia and founded several acquired companies.

Kyle was a Vice President with the American Cancer Society and worked to develop offices and global health partnerships in Vietnam, China, and Japan. He has been a board member of many global health service organizations and is currently the head of Corporate Relations for the Leukemia and Lymphoma Society of Washington and Alaska Board of Trustees. Kyle has been a city councilman, health advocate and was a twenty-year member of the Washington State Bar Association.

Sen Wen, CTO

Sen WenSen has over 20 years’ experience in technology leading teams to build world class consumer experiences in mobile, web, retail, health and energy space. Sen has managed the development and deployment of arguably the most successful mobile platform in history, the Starbucks mobile application and loyalty programs.  Sen has led successful software engineering projects for companies like Starbucks, Dunkin Donuts, Taco Bell, Cardfree, and the California Cancer Registry where his team built a HIPAA complaint database solution that included secure data transfer of millions of patient records. He has also lead engineering projects on several PCI complaint systems that securely collected credit card and user data, requiring 3rd party independent audits, security testing and analysis.

Alexander Moffat, Chief Product Officer

Alex MoffatAlex brings 18 years of experience as a team leader and entrepreneur. He comes from the background of a profitable small business owner in Manhattan, having spearheaded numerous successful innovations in his industry including in the areas of consumer product development, software development and light science invention. He has 10 years’ experience in software design, engineering, device development and spectrum analysis. With a diverse background in light sciences and photoproducts, Alex is uniquely qualified to lead the evolution of our light products.

Keith Kirkwood, Senior Vice President, Mechanical Engineering

Keith KirkwoodKeith has over 30 years of experience bringing complex machines to market inclusive of medical devices. Keith has managed many hardware engineering and design projects for companies like Tektronix, Welch Allyn, and Zoll Medical. He has worked to develop many impactful medical devices including the creation of heart monitors and defibrillators, prescription medication dispensers, and spinal devices.  Keith has also been an investor and advisor in the healthcare and medical technologies fields for more than a decade.

Linda Cox, Senior Vice President, Clinical Initiatives

Linda CoxPrior to joining BeneSol, Linda spent two decades in the health technology industry leading and consulting on complex R & D projects, several of which have been disruptive technologies requiring unique approaches to product design, development and marketplace positioning. Her industry experience ranges from working with early stage companies through IPO – managing several consecutive product life cycles – to consulting with Fortune 500 companies in the wireless health innovation arena. With deep expertise in Class II FDA regulated products, Linda has played a key role in navigating the regulatory phases required to bring a product to market. Her industry experience includes go-to-market strategies for medical devices, wireless medical and handheld wireless systems, HIPAA compliant cloud based systems, custom software applications, RF and cellular communications. Linda holds a BS in Clinical Physiology from Northeastern University. She spent the first decade of her career applying evidence-based practices and contributing to clinical research trials in Harvard Medical School institutions such as Beth Israel Deaconess Medical Center and Massachusetts General Hospital.

Medical and Scientific Advisors

BeneSol’s medical and scientific advisors are highly respected thought leaders of their industry. Our advisors have a deep understanding ultraviolet phototherapy, or are actively researching the effects of oral D on patient populations in their medical and academic careers. We have chosen our advisors for their industry expertise and guidance in clinical use as it applies to our novel device.

Ralph Pascualy, MD. Medical Advisor

Dr. Pascualy was the CEO of Swedish Medical Group (SMG), the physician division of Swedish Health Services that employs more than 1000 providers across nearly 110 primary care and specialty care clinics throughout the Greater Seattle area and Executive Medical Director of Swedish Medical Center. He provided vision, broad leadership and strategic management for all aspects of the physician practices and services and oversaw the Swedish post-acute care division.  With more than 25 years of successful clinical, business, and administrative healthcare experience in the Seattle area Dr. Pascualy brings a keen understanding of the healthcare industry and its future direction and was chosen as Seattle Business Magazine’s Medical Group Executive of the Year.

Ann McTiernan, MD, PhD. Medical Advisor

Dr. McTiernan focuses her research on identifying ways to prevent new or recurrent cancer with a particular emphasis on weight control, physical activity, and chemoprevention. She received her MD in Internal Medicine from New York Medical College in and her PhD in Epidemiology from the University of Washington. Dr. McTiernan is the Principal Investigator of the Komen-funded ViDA randomized controlled trial which is testing the effects of vitamin D vs. placebo on weight and breast cancer biomarkers in women undergoing a weight loss program. She is the Principal Investigator on numerous other studies involving exercise and lifestyle and their effects of various forms of cancer, including breast cancer and colon cancer. She was a member of the 2008 U.S. Department of Health and Human Services Physical Activity Guidelines Advisory Committee. Since 2010 she has been a Komen Scholar, and in 2012 she received a Citation Award from the American College of Sports Medicine for her research contributions on physical activity and health.

Clive M Liu, MD. Medical Advisor

Dr. Liu is a board-certified dermatologist specializing in all disorders of the skin with primary clinical and research interests in psoriasis, eczema, and skin cancer. Dr. Liu earned his medical degree from the New York University School of Medicine. He completed his internship in internal medicine at the Tulane University School of Medicine in New Orleans followed by a fellowship in psoriasis at the University of California, San Francisco. He next performed his dermatology residency at the University of Utah and was named Chief Resident in 2002. After residency, he joined the faculty at the University of Utah performing further research into gene expression in psoriasis. He is currently a member of the adjunct faculty at the University of Washington. Dr. Liu is a national speaker and key opinion leader in psoriasis. He has been the honorary medical director of the National Psoriasis Foundation Walk and is a member its President Circle. He also volunteers at the Veteran Affairs Medical Center as a member of the clinic staff. His is working toward establishing an acclaimed center for the research and treatment of psoriasis and other inflammatory skin conditions.

Michael F. Holick, MD, PhD. Medical and Scientific Advisor

Dr. Holick is Professor of Medicine, Physiology and Biophysics; Emeritus Chief of Endocrinology, Diabetes, and Nutrition; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center. Dr. Holick holds a Ph.D. degree in biochemistry, and an MD from the University of Wisconsin and completed. Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. He has established global recommendations advising sunlight exposure as an integral source of vitamin D and helped increase awareness in the pediatric and medical communities regarding vitamin D deficiency pandemic, and its role not only in causing metabolic bone disease and osteoporosis in adults, but increasing risk of children and adults developing multiple diseases. Dr. Holick pioneered a novel treatment for psoriasis through research demonstrating that the active form of vitamin D could be used for the treatment of this skin disorder. This treatment is considered to be the first line treatment for most patients with mild psoriasis.

Bernard Goffe, MD. Medical Advisor

Dr. Bernard Goffe is a board-certified dermatologist in Seattle, Washington and is affiliated with Swedish Medical Center-Cherry Hill. He is the Founder of Dermatology Associates, PLLC, a Psoriasis Treatment & Research Center in Seattle, Washington. Dr. Goffe is also a Clinical Professor in the Division of Dermatology at the University of Washington School of Medicine where he received his medical degree.

William Grant, PhD. Advisor

William B. Grant has a Ph.D. in physics from the University of California, Berkeley (1971). He had a 30-year career in atmospheric sciences with an emphasis on laser remote sensing of atmospheric constituents such as ozone and aerosols, with positions at SRI International (1973-79), the Jet Propulsion Laboratory/California Institute of Technology (1979-89) and NASA Langley Research Center (1989-2004). He turned to health research in 1996, publishing the first paper linking diet to risk of Alzheimer’s disease in 1997, followed by studies of sugar, fat and coronary heart disease in 1998, and animal products and cancer risk in 1998. In 1999 he turned his attention to the role of solar ultraviolet-B exposure in reducing risk of many types of cancer through production of vitamin D in 2002. After retirement from NASA in 2004, he moved to San Francisco and formed the nonprofit organization Sunlight, Nutrition and Health Research Center (www.sunarc.org), where he spends most of his time studying the role of solar UVB exposure and vitamin D in reducing risk of cancer and many other types of disease. He also investigates the role of diet in risk of chronic diseases. He has about 300 health publications listed at http://www.pubmed.gov , of which 210 are related to vitamin D, with 78 of these also on ultraviolet radiation and human health, and 41 to diet and disease.

Ben Lynch, ND, Advisor

Dr. Benjamin Lynch, ND received his Cell and Molecular Biology, BS from the University of Washington and his doctorate in Naturopathic Medicine (ND) from Bastyr University. His passion for identifying the cause of disease directed him towards nutrigenomics and methylation dysfunction. Ben is the Chief Medical Officer for SeekingHealth.com. He is a genetic pioneer and researches, writes and presents worldwide on the topic of the MTHFR gene, methylation defects and genetic control.